Inherited genetic variants help identify patients at higher risk of aggressive therapy-related blood cancers

Some patients develop aggressive blood cancers years after receiving chemotherapy or radiotherapy for a previous cancer. These conditions, known as therapy-related myeloid neoplasms (t-MN), are currently classified mainly according to a patient's treatment history, even though their clinical course can vary considerably from one person to another.